Essex Investment Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-167,756
| Closed | -$2.28M | – | 476 |
|
|
2018
Q3 | $2.28M | Sell |
167,756
-431
| -0.3% | -$5.85K | 0.27% | 106 |
|
|
2018
Q2 | $2M | Sell |
168,187
-205,830
| -55% | -$2.44M | 0.25% | 115 |
|
|
2018
Q1 | $4.2M | Buy |
374,017
+286,710
| +328% | +$3.22M | 0.55% | 43 |
|
|
2017
Q4 | $583K | Buy |
87,307
+14,311
| +20% | +$95.6K | 0.08% | 259 |
|
|
2017
Q3 | $598K | Sell |
72,996
-119,049
| -62% | -$975K | 0.08% | 252 |
|
|
2017
Q2 | $862K | Buy |
192,045
+151,273
| +371% | +$679K | 0.12% | 213 |
|
|
2017
Q1 | $225K | Buy |
+40,772
| New | +$225K | 0.04% | 314 |
|
|
2016
Q2 | – | Sell |
-60,575
| Closed | -$492K | – | 317 |
|
|
2016
Q1 | $492K | Buy |
+60,575
| New | +$492K | 0.08% | 232 |
|